Medicaid's role in improving substance use disorder treatment in the US

Medicaid's role in improving substance use disorder treatment in the US

Collection:
Health Policy and Services Research
Author(s):
Donohue, Julie, author
Raslevich, Amy C., author
Cole, Evan, author
Contributor(s):
Milbank Memorial Fund, issuing body.
Publication:
New York, NY : Milbank Memorial Fund, [2020]
Language(s):
English
Format:
Text
Subject(s):
Government Regulation
Medicaid
Role
Substance-Related Disorders -- therapy
United States
Centers for Medicare & Medicaid Services (U.S.)
Genre(s):
Technical Report
Abstract:
As the nation's largest payer for substance use disorder treatment (SUD) and recovery services, Medicaid plays a significant role in shaping the delivery and reimbursement of such services not only for the program's beneficiaries but more broadly for commercially insured and Medicare populations. Nationally, Medicaid covers nearly 40% of all individuals with an opioid use disorder (OUD) and a greater share in states that expanded Medicaid under the Affordable Care Act. Medicaid plays an even larger role for high-risk populations with SUDs, including pregnant women and justice-involved persons who are disproportionally insured by Medicaid. State Medicaid programs influence SUD treatment and recovery systems in several different ways (Figure 1). This primer examines the policy levers available to improve access and quality of SUD treatment and recovery services.
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (4 pages, 1 unnumbered page))
Illustrations:
Illustrations
NLM Unique ID:
9918350187606676 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/9918350187606676